Imaging

Letter to the Editor
Should Patients With Critical Limb Ischemia Undergo Routine Coronary Angiography to Detect Coronary Artery Disease?
12/01/2015
Does the strategy of routine coronary angiography and subsequent coronary revascularization based upon clinical judgment represent a reasonable treatment strategy for patients with CLI who are at high risk for cardiovascular events?
Does the strategy of routine coronary angiography and subsequent coronary revascularization based upon clinical judgment represent a reasonable treatment strategy for patients with CLI who are at high risk for cardiovascular events?
Does the strategy of routine...
12/01/2015
Vascular Disease Management
Clinical Editor's Corner
Routine Angiography for Critical Limb Ischemia
11/30/2015
Dr. Walker responds to a letter to the editor that considers the question of whether critical limb ischemia patients should undergo angiography to detect coronary artery disease.
Dr. Walker responds to a letter to the editor that considers the question of whether critical limb ischemia patients should undergo angiography to detect coronary artery disease.
Dr. Walker responds to a letter...
11/30/2015
Vascular Disease Management
Interview
A Study of CO2 Angiography in Critical Limb Ischemia Patients With Kidney Disease: Interview With Larry J. Diaz-Sandoval, MD
08/29/2015
Larry J. Diaz-Sandoval, MD, discusses a study of CO2 angiography conducted on critical limb ischemia patients with diabetes and chronic kidney disease. 
Larry J. Diaz-Sandoval, MD, discusses a study of CO2 angiography conducted on critical limb ischemia patients with diabetes and chronic kidney disease. 
Larry J. Diaz-Sandoval, MD,...
08/29/2015
Vascular Disease Management
Interview
Interim Data From the VISION OCT Image-Guided Atherectomy Trial
07/01/2015
At the 2015 New Cardiovascular Horizons meeting, Vascular Disease Management spoke with VISION trial investigator Patrick Muck, MD, and Avinger founder and CEO John B. Simpson, MD, about the VISION trial and the Pantheris system.
At the 2015 New Cardiovascular Horizons meeting, Vascular Disease Management spoke with VISION trial investigator Patrick Muck, MD, and Avinger founder and CEO John B. Simpson, MD, about the VISION trial and the Pantheris system.
At the 2015 New Cardiovascular...
07/01/2015
Vascular Disease Management
Interview
Craig Walker, MD, Discusses 12-Month Data From EXCITE ISR
07/01/2015
Dr. Walker, an interventional cardiologist with Cardiovascular Institute of the South and a clinical professor of medicine at Tulane University and LSU medical schools, served as an EXCITE ISR co-principal investigator. Vascular Disease...
Dr. Walker, an interventional cardiologist with Cardiovascular Institute of the South and a clinical professor of medicine at Tulane University and LSU medical schools, served as an EXCITE ISR co-principal investigator. Vascular Disease...
Dr. Walker, an interventional...
07/01/2015
Vascular Disease Management
News
An Update on the Status of Critical Limb Ischemia
12/03/2014
The last few years have seen advancement in the definition, diagnosis, and treatment of critical limb ischemia. In this editorial, Dr. Walker highlights some of the more important changes.
The last few years have seen advancement in the definition, diagnosis, and treatment of critical limb ischemia. In this editorial, Dr. Walker highlights some of the more important changes.
The last few years have seen...
12/03/2014
Vascular Disease Management

Upcoming Events

February 2 ⁠–⁠ February 5
Western AF Symposium
February 27 ⁠–⁠ March 1
DCLF
March 17 ⁠–⁠ March 19
NP Institute
March 27 ⁠–⁠ March 30
TCIV
March 31 ⁠–⁠ April 2
Rx summit logo
April 21 ⁠–⁠ April 24
SAWC Spring
April 30 ⁠–⁠ May 4
Symposium on Advanced Wound Care
April 30 ⁠–⁠ May 5
WoundCon
May 1 ⁠–⁠ May 3
Senior Living Executive Conference
May 19 ⁠–⁠ May 21
See Full Calendar

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use